Annual Cash & Cash Equivalents:
$319.74M+$262.88M(+462.36%)Summary
- As of today, ZBIO annual cash & cash equivalents is $319.74 million, with the most recent change of +$262.88 million (+462.36%) on December 31, 2024.
- During the last 3 years, ZBIO annual cash & cash equivalents has risen by +$252.53 million (+375.74%).
- ZBIO annual cash & cash equivalents is now at all-time high.
Performance
ZBIO Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$273.28M-$39.10M(-12.52%)Summary
- As of today, ZBIO quarterly cash & cash equivalents is $273.28 million, with the most recent change of -$39.10 million (-12.52%) on June 30, 2025.
- Over the past year, ZBIO quarterly cash & cash equivalents has increased by +$89.35 million (+48.58%).
- ZBIO quarterly cash & cash equivalents is now -29.35% below its all-time high of $386.80 million, reached on September 30, 2024.
Performance
ZBIO Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ZBIO Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +462.4% | +48.6% |
| 3Y3 Years | +375.7% | +306.6% |
| 5Y5 Years | +375.7% | +306.6% |
ZBIO Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +462.4% | -29.4% | +635.5% |
| 5Y | 5-Year | at high | +462.4% | -29.4% | +635.5% |
| All-Time | All-Time | at high | +462.4% | -29.4% | +635.5% |
ZBIO Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $273.28M(-12.5%) |
| Mar 2025 | - | $312.38M(-11.0%) |
| Dec 2024 | $319.74M | $350.86M(-9.3%) |
| Sep 2024 | - | $386.80M(+110.3%) |
| Jun 2024 | - | $183.93M(+395.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $37.15M(-34.7%) |
| Dec 2023 | $56.86M(-15.4%) | - |
| Dec 2023 | - | $56.86M(-21.4%) |
| Sep 2023 | - | $72.31M(+7.6%) |
| Dec 2022 | $67.21M | $67.21M |
FAQ
- What is Zenas BioPharma, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Zenas BioPharma, Inc.?
- What is Zenas BioPharma, Inc. annual cash & cash equivalents year-on-year change?
- What is Zenas BioPharma, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Zenas BioPharma, Inc.?
- What is Zenas BioPharma, Inc. quarterly cash & cash equivalents year-on-year change?
What is Zenas BioPharma, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ZBIO is $319.74M
What is the all-time high annual cash & cash equivalents for Zenas BioPharma, Inc.?
Zenas BioPharma, Inc. all-time high annual cash & cash equivalents is $319.74M
What is Zenas BioPharma, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ZBIO annual cash & cash equivalents has changed by +$262.88M (+462.36%)
What is Zenas BioPharma, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ZBIO is $273.28M
What is the all-time high quarterly cash & cash equivalents for Zenas BioPharma, Inc.?
Zenas BioPharma, Inc. all-time high quarterly cash & cash equivalents is $386.80M
What is Zenas BioPharma, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ZBIO quarterly cash & cash equivalents has changed by +$89.35M (+48.58%)